Drug Pricing and Cost Work

Drug pricing is a key issue in the United States, and CP3 faculty regularly use their expertise to contribute to public discourse on many aspects of drug pricing and health care costs.

News Interviews
WPXI Interviews Hernandez about Rising Prices for MS Drugs
Drug Pricing Is a "Huge Debate," Gellad tells PG
Marketplace Interviews Gellad About Drug Pricing

Published Viewpoints
Drug Shortages in the United States: Are Some Prices Too Low?
Inmaculada Hernandez, PharmD, PhD; Tina Batra Hershey, JD, MPH; Julie M. Donohue, PhD
JAMA, March 3, 2020

Adalimumab and the Challenges for Biosimilars
Walid F. Gellad, MD, MPH; Chester B. Good, MD, MPH
JAMA, October 23, 2019

Prescription 2020: Democratic Candidates And Drug Pricing
Rohan Chalasani, Julie M. Donohue, Walid F. Gellad
Health Affairs Blog, August 29, 2019

A New Safe Harbor — Turning Drug Rebates into Discounts in Medicare Part D
Walid F. Gellad, MD, MPH, Molly Ennis, MPH, and Courtney C. Kuza, PhD, MPH
The New England Journal of Medicine, April 3, 2019

Published Research
Changes in List Prices, Net Prices, and Discounts for Branded Drugs in the US, 2007-2018
Inmaculada Hernandez, PharmD, PhD; Alvaro San-Juan-Rodriguez, PharmD; Chester B. Good, MD, MPH; Walid F. Gellad, MD, MPH
JAMA, March 3, 2020

Trends in Prices, Market Share, and Spending on Self-administered Disease-Modifying Therapies for Multiple Sclerosis in Medicare Part D
Alvaro San-Juan-Rodriguez, PharmD; Chester B. Good, MD, MPH; Rock A. Heyman, MD; Natasha Parekh, MD, MS; William H. Shrank, MD, MSHS; Inmaculada Hernandez, PharmD, PhD
JAMA Neurology, August 26, 2019

Savings from the EpiPen Authorized Generic: a Retrospective Analysis of Medicaid Data
Inmaculada Hernandez, William H. Shrank, Chester B. Good, Walid F. Gellad
Journal of General Internal Medicine, April 3, 2019

Assessment of Price Changes of Existing Tumor Necrosis Factor Inhibitors After the Market Entry of Competitors
Alvaro San-Juan-Rodriguez, PharmD; Max V. Prokopovich, BS; William H. Shrank, MD, MSHS; Chester B. Good, MD, MPH; Inmaculada Hernandez, PharmD, PhD
JAMA Internal Medicine, February 18, 2019

All recently published work in drug pricing and cost